Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting

The study of pathogenic viruses has always posed significant biosafety challenges. In particular, the study of highly pathogenic viruses requires methods with low biological risk but relatively high sensitivity and convenience in detection. In recent years, pseudoviruses, which consist of a backbone...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofiia N. Rizatdinova, Alina E. Ershova, Irina V. Astrakhantseva
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/1/135
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588922408927232
author Sofiia N. Rizatdinova
Alina E. Ershova
Irina V. Astrakhantseva
author_facet Sofiia N. Rizatdinova
Alina E. Ershova
Irina V. Astrakhantseva
author_sort Sofiia N. Rizatdinova
collection DOAJ
description The study of pathogenic viruses has always posed significant biosafety challenges. In particular, the study of highly pathogenic viruses requires methods with low biological risk but relatively high sensitivity and convenience in detection. In recent years, pseudoviruses, which consist of a backbone of one virus and envelope proteins of another virus, have become one of the most widely used tools for exploring the mechanisms of viruses binding to cells, membrane fusion and viral entry, as well as for screening the libraries of antiviral substances, evaluating the potential of neutralizing monoclonal antibodies, developing neutralization tests, and therapeutic platforms. During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pseudotyped virus-based assays played a pivotal role in advancing our understanding of virus–cell interactions and the role of its proteins in disease pathogenesis. Such tools facilitated the search for potential therapeutic agents and accelerated epidemiological studies on post-infection and post-vaccination humoral immunity. This review focuses on the use of pseudoviruses as a model for large-scale applications to study enveloped viruses.
format Article
id doaj-art-a3a158074a854a85a7c758b73b58c41e
institution Kabale University
issn 2218-273X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-a3a158074a854a85a7c758b73b58c41e2025-01-24T13:25:19ZengMDPI AGBiomolecules2218-273X2025-01-0115113510.3390/biom15010135Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory SettingSofiia N. Rizatdinova0Alina E. Ershova1Irina V. Astrakhantseva2Department of Immunobiology and Biomedicine, Sirius University of Science and Technology, 354349 Sirius, Krasnodarsky Krai, RussiaDepartment of Immunobiology and Biomedicine, Sirius University of Science and Technology, 354349 Sirius, Krasnodarsky Krai, RussiaDepartment of Immunobiology and Biomedicine, Sirius University of Science and Technology, 354349 Sirius, Krasnodarsky Krai, RussiaThe study of pathogenic viruses has always posed significant biosafety challenges. In particular, the study of highly pathogenic viruses requires methods with low biological risk but relatively high sensitivity and convenience in detection. In recent years, pseudoviruses, which consist of a backbone of one virus and envelope proteins of another virus, have become one of the most widely used tools for exploring the mechanisms of viruses binding to cells, membrane fusion and viral entry, as well as for screening the libraries of antiviral substances, evaluating the potential of neutralizing monoclonal antibodies, developing neutralization tests, and therapeutic platforms. During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pseudotyped virus-based assays played a pivotal role in advancing our understanding of virus–cell interactions and the role of its proteins in disease pathogenesis. Such tools facilitated the search for potential therapeutic agents and accelerated epidemiological studies on post-infection and post-vaccination humoral immunity. This review focuses on the use of pseudoviruses as a model for large-scale applications to study enveloped viruses.https://www.mdpi.com/2218-273X/15/1/135viral infectionin vitro modelpseudoviral particlesneutralizing antibodiesSARS-CoV-2
spellingShingle Sofiia N. Rizatdinova
Alina E. Ershova
Irina V. Astrakhantseva
Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
Biomolecules
viral infection
in vitro model
pseudoviral particles
neutralizing antibodies
SARS-CoV-2
title Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
title_full Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
title_fullStr Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
title_full_unstemmed Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
title_short Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
title_sort pseudotyped viruses a useful platform for pre clinical studies conducted in a bsl 2 laboratory setting
topic viral infection
in vitro model
pseudoviral particles
neutralizing antibodies
SARS-CoV-2
url https://www.mdpi.com/2218-273X/15/1/135
work_keys_str_mv AT sofiianrizatdinova pseudotypedvirusesausefulplatformforpreclinicalstudiesconductedinabsl2laboratorysetting
AT alinaeershova pseudotypedvirusesausefulplatformforpreclinicalstudiesconductedinabsl2laboratorysetting
AT irinavastrakhantseva pseudotypedvirusesausefulplatformforpreclinicalstudiesconductedinabsl2laboratorysetting